M. Allevato

发表

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

J. Mesirov, S. Schokrpur, B. Fox, 2022, Nature Communications.

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

L. Alexandrov, M. Gilardi, Zhiyong Wang, 2019, Nature Communications.

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy

Dina V. Hingorani, S. Adams, J. S. Gutkind, 2022, Nature Communications.

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer

J. Grandis, J. Califano, M. Gilardi, 2021, Nature Communications.

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs

Eugene Bolotin, Ernest Martinez, Eugene Bolotin, 2017, PloS one.

Sequence-specific DNA binding by to low-affinity non-E-box motifs.

Eugene Bolotin, E. Martinez, M. Sladek, 2017 .

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs

Eugene Bolotin, F. Sladek, E. Martinez, 2017, PloS one.

of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in and

J. Grandis, J. Califano, M. Gilardi, 2021 .

4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.

S. Lippman, N. Sonenberg, J. Califano, 2019, Cancer research.

HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers

Alexander V. Favorov, Daria A. Gaykalova, T. Ideker, 2020, Oncogene.

601 Sequencing immunotherapy before lymphatic ablation unleashes cDC1-dependent antitumor immunity in HNSCC

B. Fox, J. Califano, Zhiyong Wang, 2021, Journal for ImmunoTherapy of Cancer.

Novel syngeneic animal model of tobacco-associated oral cancer reveals the activity of in situ anti-CTLA-4

L. Alexandrov, M. Gilardi, Zhiyong Wang, 2019, bioRxiv.

Tumor-Derived Exosomes and the Role of Liquid Biopsy in Human Papillomavirus Oropharyngeal Squamous Cell Carcinoma

M. Brenner, S. Chinn, M. Allevato, 2023, Cancer journal.

A kinome-wide synthetic lethal CRISPR/Cas9 screen reveals that mTOR inhibition prevents adaptive resistance to CDK4/CDK6 blockade in HNSCC

P. Mali, Xiaodong Feng, Xingyu Wu, 2023, bioRxiv.

A genome-wide CRISPR screen reveals that antagonism of glutamine metabolism sensitizes head and neck squamous cell carcinoma to ferroptotic cell death.

A. Molinolo, J. Watrous, Xingyu Wu, 2024, Cancer letters.